Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2011076 | 0.81 | SMN1; SMN2 (0.37) | ALDH1A1GSR | |
| SCHEMBL2802345 | 0.79 | CA1 (0.32) | ALDH1A1GSR | |
| Methane SCHEMBL2010336 | 0.79 | SMN1; SMN2 (0.36) | ALDH1A1GSR | |
| Ethane SCHEMBL2015992 | 0.79 | SMN1; SMN2 (0.36) | ALDH1A1GSR | |
| SCHEMBL2010335 | 0.78 | CA1 (0.37) | ALDH1A1GSR | |
| SCHEMBL2015989 | 0.78 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL2014543 | 0.76 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL10569376 | 0.71 | BCL9 (0.50) | ALDH1A1 | |
| SCHEMBL6053504 | 0.70 | — | — | |
| SCHEMBL8686124 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7166605-B2 | Probucol nitro-derivatives | NICOX, S.A. (FR) | 2007-01-23 | — | — | US | disclosed |
| US-20060167003-A1 | Probucol derivatives | NICOX S.A. (FR) | 2006-07-27 | — | — | US | disclosed |
| EP-1521740-A2 | PROBUCOL DERIVATIVES | Nicox S.A. (FR) | 2005-04-13 | — | — | EP | disclosed |
| WO-2003080568-A2 | PROBUCOL DERIVATIVES | NICOX S.A. (FR) | 2003-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167003-A1 | Probucol derivatives | PNLIP, APOB, LIPC | ALDH1A1 511/4885GSR 807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.